Topical Drug Shows Promise for Diabetic Macular Edema

Early clinical trial data show that a topical drug called mecamylamine is safe to use and can slow the progress of a severe form of eye disease in people with type 1 diabetes. Because this potential treatment can be self-administered, it may also ease the burdens of healthcare costs and compliance.

Ask a Medical Professional: Diabetes Myths and Misconceptions

By Catherine Marschilok, M.S.N., C.D.E., Board Certified in Advanced Diabetes Management We all know a diagnosis of type 1 diabetes (T1D) is hard on families as they learn to cope with a number of changes in their daily life. While people care, it is all too common for them to ask questions that reflect a […]